Baker Bros. Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Baker Bros. Advisors’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-249,968	Closed	-$1.67M	–	103
2023 Q3	$1.67M	Sell	249,968 -919,135	-79%	-$7.64M	0.01%	89
2023 Q2	$10.6M	Hold	1,169,103	–	–	0.06%	54
2023 Q1	$8.5M	Hold	1,169,103	–	–	0.05%	56
2022 Q4	$8.52M	Hold	1,169,103	–	–	0.05%	62
2022 Q3	$9.04M	Buy	+1,169,103	New	+$9.92M	0.06%	64

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baker Bros. Advisors's PNT Position: Q4 2023 in Review

Baker Bros. Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 249,968 shares — an estimated $1.67M sold.

Baker Bros. Advisors first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $10.6M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Baker Bros. Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Baker Bros. Advisors sold 249,968 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $1.67M.
Baker Bros. Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Baker Bros. Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $10.6M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Baker Bros. Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.